Biotechnology in Spain
Published: August 2013 · Publisher: MarketLine
Biotechnology in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017).
- Description
- Companies Mentioned
- Table of Contents
- Ask a Question
Introduction
Biotechnology in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Spain biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
*The Spanish biotechnology market had total revenues of $24.4bn in 2012, representing a compound annual growth rate (CAGR) of 25.8% between 2008 and 2012.
*During the years of the crisis the market has not stopped growing, creating more than 250 new biotechnology companies with a net job creation of over 3,000 jobs since 2008.
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 10.0% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $39.3bn by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Spain
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Spain
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Spain biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Spain economy
Key Questions Answered
What was the size of the Spain biotechnology market by value in 2012?
What will be the size of the Spain biotechnology market in 2017?
What factors are affecting the strength of competition in the Spain biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Spain's biotechnology market?
Biotechnology in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Spain biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
*The Spanish biotechnology market had total revenues of $24.4bn in 2012, representing a compound annual growth rate (CAGR) of 25.8% between 2008 and 2012.
*During the years of the crisis the market has not stopped growing, creating more than 250 new biotechnology companies with a net job creation of over 3,000 jobs since 2008.
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 10.0% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $39.3bn by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Spain
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Spain
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Spain biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Spain economy
Key Questions Answered
What was the size of the Spain biotechnology market by value in 2012?
What will be the size of the Spain biotechnology market in 2017?
What factors are affecting the strength of competition in the Spain biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Spain's biotechnology market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Esteve Group, Grifols, S.A. and Zeltia, S.A.
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Esteve Group 19
Grifols, S.A. 20
Zeltia, S.A. 23
Macroeconomic Indicators 25
Country Data 25
Appendix 27
Methodology 27
Industry associations 28
Related research 28
LIST OF TABLES
Table 1: Spain biotechnology market value: $ billion, 2008–12 8
Table 2: Spain biotechnology market category segmentation: $ billion, 2012 9
Table 3: Spain biotechnology market geography segmentation: $ billion, 2012 10
Table 4: Spain biotechnology market value forecast: $ billion, 2012–17 11
Table 5: Esteve Group: key facts 19
Table 6: Grifols, S.A.: key facts 20
Table 7: Grifols, S.A.: key financials ($) 21
Table 8: Grifols, S.A.: key financials (€) 21
Table 9: Grifols, S.A.: key financial ratios 21
Table 10: Zeltia, S.A.: key facts 23
Table 11: Zeltia, S.A.: key financials ($) 23
Table 12: Zeltia, S.A.: key financials (€) 24
Table 13: Zeltia, S.A.: key financial ratios 24
Table 14: Spain size of population (million), 2008–12 25
Table 15: Spain gdp (constant 2000 prices, $ billion), 2008–12 25
Table 16: Spain gdp (current prices, $ billion), 2008–12 25
Table 17: Spain inflation, 2008–12 26
Table 18: Spain consumer price index (absolute), 2008–12 26
Table 19: Spain exchange rate, 2008–12 26
LIST OF FIGURES
Figure 1: Spain biotechnology market value: $ billion, 2008–12 8
Figure 2: Spain biotechnology market category segmentation: % share, by value, 2012 9
Figure 3: Spain biotechnology market geography segmentation: % share, by value, 2012 10
Figure 4: Spain biotechnology market value forecast: $ billion, 2012–17 11
Figure 5: Forces driving competition in the biotechnology market in Spain, 2012 12
Figure 6: Drivers of buyer power in the biotechnology market in Spain, 2012 13
Figure 7: Drivers of supplier power in the biotechnology market in Spain, 2012 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in Spain, 2012 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in Spain, 2012 17
Figure 10: Drivers of degree of rivalry in the biotechnology market in Spain, 2012 18
Figure 11: Grifols, S.A.: revenues & profitability 22
Figure 12: Grifols, S.A.: assets & liabilities 22
Figure 13: Zeltia, S.A.: revenues & profitability 24
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Esteve Group 19
Grifols, S.A. 20
Zeltia, S.A. 23
Macroeconomic Indicators 25
Country Data 25
Appendix 27
Methodology 27
Industry associations 28
Related research 28
LIST OF TABLES
Table 1: Spain biotechnology market value: $ billion, 2008–12 8
Table 2: Spain biotechnology market category segmentation: $ billion, 2012 9
Table 3: Spain biotechnology market geography segmentation: $ billion, 2012 10
Table 4: Spain biotechnology market value forecast: $ billion, 2012–17 11
Table 5: Esteve Group: key facts 19
Table 6: Grifols, S.A.: key facts 20
Table 7: Grifols, S.A.: key financials ($) 21
Table 8: Grifols, S.A.: key financials (€) 21
Table 9: Grifols, S.A.: key financial ratios 21
Table 10: Zeltia, S.A.: key facts 23
Table 11: Zeltia, S.A.: key financials ($) 23
Table 12: Zeltia, S.A.: key financials (€) 24
Table 13: Zeltia, S.A.: key financial ratios 24
Table 14: Spain size of population (million), 2008–12 25
Table 15: Spain gdp (constant 2000 prices, $ billion), 2008–12 25
Table 16: Spain gdp (current prices, $ billion), 2008–12 25
Table 17: Spain inflation, 2008–12 26
Table 18: Spain consumer price index (absolute), 2008–12 26
Table 19: Spain exchange rate, 2008–12 26
LIST OF FIGURES
Figure 1: Spain biotechnology market value: $ billion, 2008–12 8
Figure 2: Spain biotechnology market category segmentation: % share, by value, 2012 9
Figure 3: Spain biotechnology market geography segmentation: % share, by value, 2012 10
Figure 4: Spain biotechnology market value forecast: $ billion, 2012–17 11
Figure 5: Forces driving competition in the biotechnology market in Spain, 2012 12
Figure 6: Drivers of buyer power in the biotechnology market in Spain, 2012 13
Figure 7: Drivers of supplier power in the biotechnology market in Spain, 2012 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in Spain, 2012 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in Spain, 2012 17
Figure 10: Drivers of degree of rivalry in the biotechnology market in Spain, 2012 18
Figure 11: Grifols, S.A.: revenues & profitability 22
Figure 12: Grifols, S.A.: assets & liabilities 22
Figure 13: Zeltia, S.A.: revenues & profitability 24
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.